SOURCE beyond first‐line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first‐line palliative systemic therapy

Prior models have been developed to predict survival for patients with esophagogastric cancer undergoing curative treatment or first‐line chemotherapy (SOURCE models). Comprehensive clinical prediction models for patients with esophagogastric cancer who will receive second‐line chemotherapy or best...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuijper, Steven C., Pape, Marieke, Haj Mohammad, Nadia, van Voorthuizen, Theo, Verhoeven, Rob H. A., van Laarhoven, Hanneke W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Innovative Tools and Methods
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107625/
https://www.ncbi.nlm.nih.gov/pubmed/36451334
http://dx.doi.org/10.1002/ijc.34385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107625/
https://www.ncbi.nlm.nih.gov/pubmed/36451334
http://dx.doi.org/10.1002/ijc.34385

Ejemplares similares